Inverness Medical Innovations (IMA)
Q1 2010 Earnings Call
April 28, 2010 10:00 am ET
Doug Guarino - Director of Corporate Communications & Corporate Relations
David Teitel - Chief Financial Officer, Principal Accounting Officer, Vice President and Treasurer
Ron Zwanziger - Chairman of the Board, Chief Executive Officer and President
Bruce Cranna - Jefferies & Company, Inc.
Ashim Anand - Natixis Bleichroeder Inc.
Erik Schneider - UBS Investment Bank
Bill Bonello - RBC Capital Markets Corporation
Jonathan Groberg - Macquarie Research
Gregory Simpson - Stifel, Nicolaus & Co., Inc.
Mark Afrasiabi - PIMCO
John Putnam - Capstone Investments
Zarak Khurshid - Caris & Company
Constantine Davides - JMP Securities LLC
Daniel Owczarski - Avondale Partners LLC
Good morning, and welcome to the First Quarter Earnings Conference Call. My name is Suzette, and I will be facilitating the audio portion of today's interactive broadcast. [Operator Instructions] At this time, I would like to turn the event over to Doug Guarino, Director of Corporate Relations. Sir, you may begin your conference.
Well, thank you, Suzette, and good morning, and welcome to the Inverness Medical Innovations Conference Call to discuss our results for the quarter and year ended March 31, 2010. We are joined today by Ron Zwanziger, Chairman and CEO; and Dave Teitel, our CFO.
Before we get to that discussion though, I would first like to draw your attention to the fact that certain matters discussed in this conference call will constitute forward-looking statements within the meaning of U.S. securities laws. These statements reflect our current views with respect to future events of financial performance and are based on management’s current assumptions and information currently available.